Pulmonomy Initiates Drug Development for COVID-19

We have initiated the rapid development of novel medicines forthe treatment of COVID-19. About Us Pulmonomy(a subsidiary of TotalClarity, Inc.) is a biopharma company, targeting a range of life-threatening infections of the lungs. (www.pulmonomy.com) is focused on...